Gene Review:
Apo - anterior polar opacity
Mus musculus
- Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior. Aalto-Setälä, K., Bisgaier, C.L., Ho, A., Kieft, K.A., Traber, M.G., Kayden, H.J., Ramakrishnan, R., Walsh, A., Essenburg, A.D., Breslow, J.L. J. Clin. Invest. (1994)
- Selection of a gene for apolipoprotein A1 using autoantibodies from a patient with systemic lupus erythematosus. Merrill, J.T., Rivkin, E., Shen, C., Lahita, R.G. Arthritis Rheum. (1995)
- New dibenzothiadiazepine derivatives with antidepressant activities. Giannotti, D., Viti, G., Sbraci, P., Pestellini, V., Volterra, G., Borsini, F., Lecci, A., Meli, A., Dapporto, P., Paoli, P. J. Med. Chem. (1991)
- Chlamydophila pneumoniae (Chlamydia pneumoniae) accelerates the formation of complex atherosclerotic lesions in Apo E3-Leiden mice. Ezzahiri, R., Nelissen-Vrancken, H.J., Kurvers, H.A., Stassen, F.R., Vliegen, I., Grauls, G.E., van Pul, M.M., Kitslaar, P.J., Bruggeman, C.A. Cardiovasc. Res. (2002)
- Apo A-I inhibits foam cell formation in Apo E-deficient mice after monocyte adherence to endothelium. Dansky, H.M., Charlton, S.A., Barlow, C.B., Tamminen, M., Smith, J.D., Frank, J.S., Breslow, J.L. J. Clin. Invest. (1999)
- Finally, a noncontroversial role for Apo A-I in HDL-mediated cholesterol flux to cells. Rothblat, G.H. J. Clin. Invest. (1996)
- Identification of a cDNA clone for mouse apoprotein A-1 (apo A-1) and its use in characterization of apo A-1 mRNA expression in liver and small intestine. Miller, J.C., Barth, R.K., Shaw, P.H., Elliott, R.W., Hastie, N.D. Proc. Natl. Acad. Sci. U.S.A. (1983)
- Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice. Lesuisse, C., Xu, G., Anderson, J., Wong, M., Jankowsky, J., Holtz, G., Gonzalez, V., Wong, P.C., Price, D.L., Tang, F., Wagner, S., Borchelt, D.R. Hum. Mol. Genet. (2001)
- Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. Mueller, T., Voigt, W., Simon, H., Fruehauf, A., Bulankin, A., Grothey, A., Schmoll, H.J. Cancer Res. (2003)
- Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17 beta-estradiol. Tse, J., Martin-McNaulty, B., Halks-Miller, M., Kauser, K., DelVecchio, V., Vergona, R., Sullivan, M.E., Rubanyi, G.M. Atherosclerosis (1999)
- Inhibition of nuclear factor kappa B and induction of apoptosis in T-lymphocytes by sulfasalazine. Liptay, S., Bachem, M., Häcker, G., Adler, G., Debatin, K.M., Schmid, R.M. Br. J. Pharmacol. (1999)
- Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans. Moghadasian, M.H., McManus, B.M., Nguyen, L.B., Shefer, S., Nadji, M., Godin, D.V., Green, T.J., Hill, J., Yang, Y., Scudamore, C.H., Frohlich, J.J. FASEB J. (2001)
- Apop-1, a novel protein inducing cyclophilin D-dependent but Bax/Bak-related channel-independent apoptosis. Yasuda, O., Fukuo, K., Sun, X., Nishitani, M., Yotsui, T., Higuchi, M., Suzuki, T., Rakugi, H., Smithies, O., Maeda, N., Ogihara, T. J. Biol. Chem. (2006)
- Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes. Phillips, M.C., Gillotte, K.L., Haynes, M.P., Johnson, W.J., Lund-Katz, S., Rothblat, G.H. Atherosclerosis (1998)
- Effects of culture substrates and normal hepatic sinusoidal cells on in vitro hepatocyte synthesis of Apo-SAA. Subrahmanyan, L., Kisilevsky, R. Scand. J. Immunol. (1988)
- Apoptosis and oncosis in the early progression of left ventricular dysfunction in the cardiomyopathic hamster. Ryoke, T., Gu, Y., Ikeda, Y., Martone, M.E., Oh, S.S., Jeon, E.S., Knowlton, K.U., Ross, J. Basic Res. Cardiol. (2002)
- Increased macrophage glutathione content reduces cell-mediated oxidation of LDL and atherosclerosis in apolipoprotein E-deficient mice. Rosenblat, M., Coleman, R., Aviram, M. Atherosclerosis (2002)
- The single proline-glutamine substitution at position 5 enhances the potency of amyloid fibril formation of murine apo A-II. Higuchi, K., Yonezu, T., Tsunasawa, S., Sakiyama, F., Takeda, T. FEBS Lett. (1986)
- Apolipoprotein C-III can specifically bind to hepatic plasma membranes. Fang, D.Z., Liu, B.W. Mol. Cell. Biochem. (2000)
- Characterization of atherosclerotic lesions in apo E3-leiden transgenic mice. Leppänen, P., Luoma, J.S., Hofker, M.H., Havekes, L.M., Ylä-Herttuala, S. Atherosclerosis (1998)
- Heterogeneity of antibodies to metallothionein isomers and development of a simple enzyme-linked immunosorbent assay. Chan, H.M., Pringle, G.A., Cherian, M.G. J. Biochem. Toxicol. (1992)
- Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Lettéron, P., Sutton, A., Mansouri, A., Fromenty, B., Pessayre, D. Hepatology (2003)
- CD36 in atherosclerosis. The role of a class B macrophage scavenger receptor. Nicholson, A.C., Febbraio, M., Han, J., Silverstein, R.L., Hajjar, D.P. Ann. N. Y. Acad. Sci. (2000)
- Recombinant mouse leukotriene A4 hydrolase: a zinc metalloenzyme with dual enzymatic activities. Wetterholm, A., Medina, J.F., Rådmark, O., Shapiro, R., Haeggström, J.Z., Vallee, B.L., Samuelsson, B. Biochim. Biophys. Acta (1991)
- Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. Cohen, R.D., Castellani, L.W., Qiao, J.H., Van Lenten, B.J., Lusis, A.J., Reue, K. J. Clin. Invest. (1997)
- Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Navab, M., Anantharamaiah, G.M., Hama, S., Garber, D.W., Chaddha, M., Hough, G., Lallone, R., Fogelman, A.M. Circulation (2002)